Enzyme-linked Immunosorbent Assay (Elisa) Market by Application, End-user and Geography - Forecast and Analysis 2023-2027

Published: Jan 2023 Pages: 178 SKU: IRTNTR41149

Enzyme-Linked Immunosorbent Assay Market Forecast 2023-2027

The enzyme-linked immunosorbent assay (Elisa) testing market size is estimated to grow by USD 564.97 million at a CAGR of 13.6% between 2022 and 2027. The growth of the market depends on several factors, including the growing need for frequent diagnostic testing among the aging population, the rise in toxicology testing in the food industry, and the increase in chronic diseases.

What will be the size of the Market During the Forecast Period?

To learn more about this report, Download Sample PDF

Market Dynamics

The increase in chronic diseases is notably driving the market growth, although factors such as a lack of trained professionals may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Driver

The increase in chronic diseases is the key factor driving the global market growth. Chronic diseases are one of the major causes of disability and death across the world. Four major chronic diseases are CVDs, cancer, chronic obstructive pulmonary disease, and type 2 diabetes, which occur due to high blood pressure, high blood cholesterol, and overweight, as well as due to unhealthy diet, physical inactivity, and tobacco use. These conditions are accelerating disease rates globally and pervading all socioeconomic classes.

Elisa tests can not only help to diagnose a disease but also manage the illness. A test result helps a doctor to assess the severity of the disease, estimate the patient's prognosis, monitor the course of disease progression, stability or resolution, detect relapse, and select drugs or adjust therapy, thus increasing the demand for Elisa testing in the diagnosis of patients, which will drive the growth of the market during the forecast period.

Significant Trends

The growing importance of promotional activities is one of the major market trends. The nature of the product, coupled with the niche end-user market, makes it difficult for companies to market these products. Unlike other assays, brand and product visibility have a limited role in the sale of Elisa tests. Emphasis is on improving the distribution network and increasing the availability of products to end-users. Advertising and marketing of these products are restricted. Also, there has been a significant lack of awareness about such products. However, leading Companies have recognized this issue and hence are promoting the use of Elisa testing through their websites.

To help end-users, Thermo Fisher Scientific offers additional support materials such as the explanation of techniques through pdf documents and brochures as well as interactive videos on YouTube. In addition, non-profit research organizations in Europe are conducting annual workshops in partnership with pharma companies to enhance awareness about Elisa tests for the early detection of diseases. As product enhancements continue in the market, Companies are beginning to realize the importance of promotional activities. This trend is set to pick up in the market and eventually support market growth during the forecast period.

Major Challenge

The stringent government regulations are a major challenge to the global market growth. The commercialization of diagnostic products is challenging as some products are classified as medical devices as they are used by physicians for diagnostic purposes. Such devices cannot be marketed without successfully completing clinical trials, which is a time-consuming, expensive, and uncertain process. Regulations for the approval of these devices vary from one country to another, which is a major challenge faced by multinational companies. In addition, any changes in regulations by different governing bodies, such as the FDA, during product development could delay the launch of potential products.

Many developed countries such as the US, the UK, Germany, France, Japan, Singapore, and South Korea have stringent regulations for the approval and marketing of diagnostic products. As these are high-income countries, the high cost of clinical trials and product launches increases the expenditure for Companies. Hence, many small companies and startup biotechnology companies seek government or private funding. However, most organizations provide limited funds to Companies. Thus, stringent government regulations in different countries will affect the development of Elisa testing products.

Key Customer Landscape

The market growth analysis report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market growth and forecasting report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Customer Landscape

Who are the Major Enzyme-linked Immunosorbent Assay (Elisa) Testing Market Companies?

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Abbott - The company offers enzyme-linked immunosorbent assays such as PBS Buffer for Forensic Matrices

The  market research and growth report also includes detailed analyses of the competitive landscape of the market and information about 15 market Companies, including:

  • Abcam plc
  • Agilent Technologies Inc.
  • Amgen Inc.
  • Avantor Inc.
  • Becton Dickinson and Co.
  • Bio Rad Laboratories Inc.
  • bioMerieux SA
  • Cardinal Health Inc.
  • Crux Biolabs Pty Ltd.
  • Danaher Corp.
  • Eppendorf SE
  • Illumina Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • Novo Nordisk AS

Qualitative and quantitative analysis of Companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize Companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize Companies as dominant, leading, strong, tentative, and weak.

Market Segmentation

The market share growth by the vaccine development segment will be significant during the forecast period. In this segment the assay technique determines the immune activity against the vaccine. These essays are usually paired along with possible inhibition assays to study the immune response to the growth of the pathogen. Elisa is one of the ligand-binding techniques that is often used to assess the humoral response to the vaccine candidate. This assay technique relies on the formation of an immune complex between the antibody and antigen. Elisa is widely used in the vaccine development process for determining the immune response toward a vaccine and to analyze the efficacy of the vaccine in preclinical stages.

Get a glance at the market contribution of various segments Request Market Research Report Sample PDF

The vaccine development segment was valued at USD 90.99 million in 2017 and continue to grow by 2021. Vaccine development and testing is a long and intensive process, including several stages, starting with an exploratory stage to identify antigens. Next, A vaccine candidate's immunogenicity and safety are assessed using animal models and preclinical cell cultures. Following the approval of an Investigational New Drug application to the US Food and Drug Administration, clinical trials begin. During the preclinical and early phases of the clinical trial, various assays are developed and validated. These assays have to pass well-characterized parameters and criteria before lot release. Eventually, a successful vaccine candidate passes through to Phase III trials to be licensed. The entire vaccine development and testing process can take more than 15 years to complete. Such factors will increase the market growth during the forecast period.

Regional Analysis

For more insights on the market share of various regions Request Market Research Report Sample PDF

North America is estimated to contribute 36% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. North America is a dominating region in the global market, with the US and Canada as the leading revenue-generating countries. Increasing demand for timely and accurate diagnosis of infectious and chronic diseases and the presence of several pharmaceutical companies in the US and Canada that are focusing on drug development is driving the adoption of Elisa testing in the region. 

Market Analyst Overview

The Enzyme-linked immunosorbent assay (ELISA) market is propelled by its versatility in detecting antibodies, biomarkers, and infectious conditions, offering cost-effective technologies for ailment diagnosis and chronic illnesses management. Automation enhances testing efficiency, with ELISA assays being widely utilized in the drug discovery domain and research applications. Multiplex proteomic array platforms enable precise protein quantification and virus testing, while sandwich ELISA remains a cornerstone in infectious diseases applications like HIV and Lyme disease diagnosis. Market growth is driven by continuous flow technology and portable ELISA devices, promising significant expansion in revenue, particularly in cancer diagnostics and immunoassays, reflecting increasing health awareness and demand for innovative disease diagnosis tools.

Segment Overview

The market forecasting report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

  • Application Outlook (USD Million, 2017 - 2027)
    • Vaccine development
    • Immunology
    • Diagnostics
    • Drug monitoring and pharmaceutical industry
    • Others
  • End-user Outlook (USD Million, 2017 - 2027)
    • Hospitals and diagnostic centers
    • Research laboratories
    • Others
  • Region Outlook (USD Million, 2017 - 2027)
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • ROW
      • Australia
      • Argentina
      • Rest of the world

Enzyme-linked Immunosorbent Assay (Elisa) Testing Market Scope

Report Coverage

Details

Page number

178

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 13.6%

Market growth 2023-2027

USD 564.97 million

Market structure

Fragmented

YoY growth 2022-2023(%)

13.26

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 36%

Key countries

US, UK, Germany, China, and Japan

Competitive landscape

 Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Key companies profiled

Abbott Laboratories, Abcam plc, Agilent Technologies Inc., Amgen Inc., Avantor Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Cardinal Health Inc., Crux Biolabs Pty Ltd., Danaher Corp., Eppendorf SE, Illumina Inc., Lonza Group Ltd., Merck KGaA, Novo Nordisk AS, Perkin Elmer Inc, QIAGEN NV, Siemens Healthineers AG, and Thermo Fisher Scientific Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request Market Research Report Sample PDF

What are the Key Data Covered in this Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the enzyme-linked immunosorbent assay testing market between 2023 and 2027
  • Precise estimation of the enzyme-linked immunosorbent assay testing market size and its contribution to the parent market
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
  • Thorough analysis of the market’s competitive landscape and detailed information about Companies
  • Comprehensive analysis of factors that will challenge the growth of market Companies

We can help! Our analysts can customize this market report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global enzyme-linked immunosorbent assay (Elisa) testing market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on Global enzyme-linked immunosorbent assay (Elisa) testing market 2017 - 2021 ($ million)
    • 4.2 Application Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Application Segment 2017 - 2021 ($ million)
    • 4.3 End User Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – End User Segment 2017 - 2021 ($ million)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Application

    • 6.1 Market segments
      • Exhibit 30: Chart on Application - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
    • 6.2 Comparison by Application
      • Exhibit 32: Chart on Comparison by Application
      • Exhibit 33: Data Table on Comparison by Application
    • 6.3 Vaccine development - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Vaccine development - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on Vaccine development - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on Vaccine development - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Vaccine development - Year-over-year growth 2022-2027 (%)
    • 6.4 Immunology - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Immunology - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on Immunology - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on Immunology - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Immunology - Year-over-year growth 2022-2027 (%)
    • 6.5 Diagnostics - Market size and forecast 2022-2027
      • Exhibit 42: Chart on Diagnostics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 43: Data Table on Diagnostics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 44: Chart on Diagnostics - Year-over-year growth 2022-2027 (%)
      • Exhibit 45: Data Table on Diagnostics - Year-over-year growth 2022-2027 (%)
    • 6.6 Drug monitoring and pharmaceutical industry - Market size and forecast 2022-2027
      • Exhibit 46: Chart on Drug monitoring and pharmaceutical industry - Market size and forecast 2022-2027 ($ million)
      • Exhibit 47: Data Table on Drug monitoring and pharmaceutical industry - Market size and forecast 2022-2027 ($ million)
      • Exhibit 48: Chart on Drug monitoring and pharmaceutical industry - Year-over-year growth 2022-2027 (%)
      • Exhibit 49: Data Table on Drug monitoring and pharmaceutical industry - Year-over-year growth 2022-2027 (%)
    • 6.7 Others - Market size and forecast 2022-2027
      • Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
      • Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
    • 6.8 Market opportunity by Application
      • Exhibit 54: Market opportunity by Application ($ million)

    7 Market Segmentation by End-user

    • 7.1 Market segments
      • Exhibit 55: Chart on End-user - Market share 2022-2027 (%)
      • Exhibit 56: Data Table on End-user - Market share 2022-2027 (%)
    • 7.2 Comparison by End-user
      • Exhibit 57: Chart on Comparison by End-user
      • Exhibit 58: Data Table on Comparison by End-user
    • 7.3 Hospitals and diagnostic centers - Market size and forecast 2022-2027
      • Exhibit 59: Chart on Hospitals and diagnostic centers - Market size and forecast 2022-2027 ($ million)
      • Exhibit 60: Data Table on Hospitals and diagnostic centers - Market size and forecast 2022-2027 ($ million)
      • Exhibit 61: Chart on Hospitals and diagnostic centers - Year-over-year growth 2022-2027 (%)
      • Exhibit 62: Data Table on Hospitals and diagnostic centers - Year-over-year growth 2022-2027 (%)
    • 7.4 Research laboratories - Market size and forecast 2022-2027
      • Exhibit 63: Chart on Research laboratories - Market size and forecast 2022-2027 ($ million)
      • Exhibit 64: Data Table on Research laboratories - Market size and forecast 2022-2027 ($ million)
      • Exhibit 65: Chart on Research laboratories - Year-over-year growth 2022-2027 (%)
      • Exhibit 66: Data Table on Research laboratories - Year-over-year growth 2022-2027 (%)
    • 7.5 Others - Market size and forecast 2022-2027
      • Exhibit 67: Chart on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 68: Data Table on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 69: Chart on Others - Year-over-year growth 2022-2027 (%)
      • Exhibit 70: Data Table on Others - Year-over-year growth 2022-2027 (%)
    • 7.6 Market opportunity by End-user
      • Exhibit 71: Market opportunity by End-user ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 73: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 74: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 75: Chart on Geographic comparison
      • Exhibit 76: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 77: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 78: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 79: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 80: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Europe - Market size and forecast 2022-2027
      • Exhibit 81: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 82: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 83: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 84: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.5 Asia - Market size and forecast 2022-2027
      • Exhibit 85: Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 86: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 87: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 88: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 89: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 90: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 91: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 92: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 93: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 94: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 95: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 96: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 China - Market size and forecast 2022-2027
      • Exhibit 97: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 98: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 99: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 100: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.9 UK - Market size and forecast 2022-2027
      • Exhibit 101: Chart on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 102: Data Table on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 103: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 104: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.10 Germany - Market size and forecast 2022-2027
      • Exhibit 105: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 106: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 107: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 108: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.11 Japan - Market size and forecast 2022-2027
      • Exhibit 109: Chart on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 110: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 111: Chart on Japan - Year-over-year growth 2022-2027 (%)
      • Exhibit 112: Data Table on Japan - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 113: Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 114: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 115: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 116: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 117: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 118: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 119: Matrix on vendor position and classification
            • 12.3 Abbott Laboratories
              • Exhibit 120: Abbott Laboratories - Overview
              • Exhibit 121: Abbott Laboratories - Business segments
              • Exhibit 122: Abbott Laboratories - Key news
              • Exhibit 123: Abbott Laboratories - Key offerings
              • Exhibit 124: Abbott Laboratories - Segment focus
            • 12.4 Abcam plc
              • Exhibit 125: Abcam plc - Overview
              • Exhibit 126: Abcam plc - Product / Service
              • Exhibit 127: Abcam plc - Key news
              • Exhibit 128: Abcam plc - Key offerings
            • 12.5 Agilent Technologies Inc.
              • Exhibit 129: Agilent Technologies Inc. - Overview
              • Exhibit 130: Agilent Technologies Inc. - Business segments
              • Exhibit 131: Agilent Technologies Inc. - Key news
              • Exhibit 132: Agilent Technologies Inc. - Key offerings
              • Exhibit 133: Agilent Technologies Inc. - Segment focus
            • 12.6 Avantor Inc.
              • Exhibit 134: Avantor Inc. - Overview
              • Exhibit 135: Avantor Inc. - Business segments
              • Exhibit 136: Avantor Inc. - Key offerings
              • Exhibit 137: Avantor Inc. - Segment focus
            • 12.7 Becton Dickinson and Co.
              • Exhibit 138: Becton Dickinson and Co. - Overview
              • Exhibit 139: Becton Dickinson and Co. - Business segments
              • Exhibit 140: Becton Dickinson and Co. - Key news
              • Exhibit 141: Becton Dickinson and Co. - Key offerings
              • Exhibit 142: Becton Dickinson and Co. - Segment focus
            • 12.8 Bio Rad Laboratories Inc.
              • Exhibit 143: Bio Rad Laboratories Inc. - Overview
              • Exhibit 144: Bio Rad Laboratories Inc. - Business segments
              • Exhibit 145: Bio Rad Laboratories Inc. - Key news
              • Exhibit 146: Bio Rad Laboratories Inc. - Key offerings
              • Exhibit 147: Bio Rad Laboratories Inc. - Segment focus
            • 12.9 bioMerieux SA
              • Exhibit 148: bioMerieux SA - Overview
              • Exhibit 149: bioMerieux SA - Product / Service
              • Exhibit 150: bioMerieux SA - Key offerings
            • 12.10 Danaher Corp.
              • Exhibit 151: Danaher Corp. - Overview
              • Exhibit 152: Danaher Corp. - Business segments
              • Exhibit 153: Danaher Corp. - Key news
              • Exhibit 154: Danaher Corp. - Key offerings
              • Exhibit 155: Danaher Corp. - Segment focus
            • 12.11 Eppendorf SE
              • Exhibit 156: Eppendorf SE - Overview
              • Exhibit 157: Eppendorf SE - Product / Service
              • Exhibit 158: Eppendorf SE - Key news
              • Exhibit 159: Eppendorf SE - Key offerings
            • 12.12 Merck KGaA
              • Exhibit 160: Merck KGaA - Overview
              • Exhibit 161: Merck KGaA - Business segments
              • Exhibit 162: Merck KGaA - Key news
              • Exhibit 163: Merck KGaA - Key offerings
              • Exhibit 164: Merck KGaA - Segment focus
            • 12.13 Novo Nordisk AS
              • Exhibit 165: Novo Nordisk AS - Overview
              • Exhibit 166: Novo Nordisk AS - Business segments
              • Exhibit 167: Novo Nordisk AS - Key offerings
              • Exhibit 168: Novo Nordisk AS - Segment focus
            • 12.14 Perkin Elmer Inc
              • Exhibit 169: Perkin Elmer Inc - Overview
              • Exhibit 170: Perkin Elmer Inc - Business segments
              • Exhibit 171: Perkin Elmer Inc - Key news
              • Exhibit 172: Perkin Elmer Inc - Key offerings
              • Exhibit 173: Perkin Elmer Inc - Segment focus
            • 12.15 QIAGEN NV
              • Exhibit 174: QIAGEN NV - Overview
              • Exhibit 175: QIAGEN NV - Product / Service
              • Exhibit 176: QIAGEN NV - Key news
              • Exhibit 177: QIAGEN NV - Key offerings
            • 12.16 Siemens Healthineers AG
              • Exhibit 178: Siemens Healthineers AG - Overview
              • Exhibit 179: Siemens Healthineers AG - Business segments
              • Exhibit 180: Siemens Healthineers AG - Key news
              • Exhibit 181: Siemens Healthineers AG - Key offerings
              • Exhibit 182: Siemens Healthineers AG - Segment focus
            • 12.17 Thermo Fisher Scientific Inc.
              • Exhibit 183: Thermo Fisher Scientific Inc. - Overview
              • Exhibit 184: Thermo Fisher Scientific Inc. - Business segments
              • Exhibit 185: Thermo Fisher Scientific Inc. - Key news
              • Exhibit 186: Thermo Fisher Scientific Inc. - Key offerings
              • Exhibit 187: Thermo Fisher Scientific Inc. - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 188: Inclusions checklist
                • Exhibit 189: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 190: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 191: Research methodology
                • Exhibit 192: Validation techniques employed for market sizing
                • Exhibit 193: Information sources
              • 13.5 List of abbreviations
                • Exhibit 194: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              enzyme-linked immunosorbent assay (elisa) testing market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis